Comparison of P2Y12 inhibitors vs. aspirin monotherapy following dual antiplatelet therapy in patients after percutaneous coronary intervention: a systematic review and meta-analysis
Archives of Medical Science – Atherosclerotic Diseases · 30.03.2026 · 11 (1) · 24-37
DOI: 10.5114/amsad/216337 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Medical Science – Atherosclerotic Diseases, online erschienen am 30.03.2026. Verfasst von Muhammad Hazqeel Kazmi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Acute Medicine, Sunderland Royal Hospital, Sunderland, UK. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
P2Y12 inhibitor monotherapy has emerged as a potential alternative to aspirin following dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI), but the optimal choice remains uncertain.
Methods
A systematic literature search compared P2Y12 inhibitors with aspirin post PCI. A random-effects model pooled odds ratios (ORs) with 95% confidence intervals (CIs) for outcomes.
Results
Seven studies (29,756 patients) were included. P2Y12 inhibitors significantly reduced MACE compared to aspirin [OR = 0.73; 95% CI: 0.64–0.84]. No significant difference was observed in all-cause mortality [OR = 0.90; 95% CI: 0.77–1.05], cardiac death [OR = 0.86; 95% CI: 0.68–1.09], major bleeding [OR = 1.06; 95% CI: 0.67–1.68], MI [OR = 0.78; 95% CI: 0.56–1.08], or stent thrombosis [OR = 0.71; 95% CI: 0.41–1.22]. P2Y12 inhibitors significantly reduced repeat revascularisation [OR = 0.83; 95% CI: 0.73–0.94] and stroke [OR = 0.63; 95% CI: 0.48–0.81].
Conclusions
P2Y12 inhibitors may be a safer, more effective alternative to aspirin alone after PCI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Acute Medicine, Sunderland Royal Hospital, Sunderland, UK.
- Department of Medicine, David Tvildiani Medical University, Tbilisi, Georgia.
- Department of Cardiology, Aria institute of medical Sciences, Quetta, Pakistan.
- Saint Vincent Hospital, Worcester, Massachusetts, USA.
- University Hospitals Plymouth NHS Trust, Plymouth, UK.
- South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
Zitieren
APA
Kazmi, M. H., Dohadwala, T. K., Haleem, S. M., Thirupathy, U., Sajnani, P., Camila, P. C. I., Ayyad, M., Ch'ng, B. X., Arshad, M. M., Nasser, I. A., Mesmar, A., Khawaja, M. N., Al-Zou'bi, A. A., Chatha, S., Tariq, O., Zulfiqar, E., Ahmed, M., & Ahmed, R. (2026). Comparison of P2Y12 inhibitors vs. aspirin monotherapy following dual antiplatelet therapy in patients after percutaneous coronary intervention: a systematic review and meta-analysis. Archives of Medical Science – Atherosclerotic Diseases, 11(1), 24-37. https://doi.org/10.5114/amsad/216337
Vancouver
Kazmi MH, Dohadwala TK, Haleem SM, Thirupathy U, Sajnani P, Camila PCI, et al. Comparison of P2Y12 inhibitors vs. aspirin monotherapy following dual antiplatelet therapy in patients after percutaneous coronary intervention: a systematic review and meta-analysis. Archives of Medical Science – Atherosclerotic Diseases. 2026;11(1):24-37. doi:10.5114/amsad/216337
BibTeX
@article{Kazmi2026,
author = {Kazmi, Muhammad Hazqeel and Dohadwala, Taha Kassim and Haleem, Syed Mohammad and Thirupathy, Umabalan and Sajnani, Piyush and Camila, Pena Campos Indira and Ayyad, Mennatalla and Ch'ng, Brandon Xian and Arshad, Muhammad Muneeb and Nasser, Ibrahim Ali and Mesmar, Ahmad and Khawaja, Muhammad Nadeem and Al-Zou'bi, Amer 'Mohammad Amin' and Chatha, Salman and Tariq, Osama and Zulfiqar, Eeshal and Ahmed, Mushood and Ahmed, Raheel},
title = {Comparison of P2Y12 inhibitors vs. aspirin monotherapy following dual antiplatelet therapy in patients after percutaneous coronary intervention: a systematic review and meta-analysis},
journal = {Archives of Medical Science – Atherosclerotic Diseases},
year = {2026},
volume = {11},
number = {1},
pages = {24--37},
doi = {10.5114/amsad/216337}
}
EUVIMED